In a stunning growth, the Central Drug Laboratory (CDL) underneath the Drug Regulatory Authority of Pakistan (DRAP) has declared a preferred injectable medicine, Paracet (Paracetamol), as substandard and adulterated.
The particular product in query is the 100ml injection, badge no. CJ170, manufactured by Stand Pharma, with an expiration date of November 20, 2024.
In line with officers at DRAP, the injection has been discovered to include black particles which can be seen to the human eye. In consequence, they’ve issued a directive to instantly cease using this injectable medicine and have additionally issued an alert to alert others of the potential hazard.
In an announcement, DRAP officers urged customers who’ve bought the affected product to discontinue use and return it to the pharmacy the place it was bought. In addition they suggested anybody experiencing issues or opposed reactions on account of utilizing this medicine to seek the advice of a health care provider instantly.
“This is a serious situation, and we are taking all necessary steps to ensure that this adulterated product is removed from the market and that consumers are protected from any potential harm,” stated an official.
This growth has brought about concern amongst sufferers and their households who’re utilizing the drugs, and amongst healthcare professionals who prescribe it. It has additionally raised questions concerning the high quality management mechanisms in place for the pharmaceutical trade in Pakistan.
